1. Abell, A.D. and Henderson, B.D. Steroidal and non-steroidal inhibitors of steroid 5a-reductase type 1. Current Medicinal Chem. 1995; 2: 583–597.
2. Akalu, A., Dimajian, D.A., Highshaw, R.A., Nichols, P.W. and Reichardt, J.K. Somatic mutations at the SRD5A2 locus encoding prostatic steroid 5alpha-reductase during prostate cancer progression. J. Urol. 1999; 161: 1355–1358.
3. Andersen, J.T., Nickel, J.C., Marshall, V.R., Schulman, C.C. and Boyle, P. Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia. Urology 1997; 49: 839–845.
4. Anderson, K.M. and Liao, S. Selective retention of dihydrotestosterone by prostatic nuclei. Nature 1968; 219: 277–279.
5. Andersson, S., Berman, D.M., Jenkins, E.P. and Russell, D.W. Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism. Nature 1991; 354: 159–161.